Pharma firms focused on talent retention, says Unispace chief

Pharma 4.0 — vital skills for next 5 years: MES engineering, data science, data management, machine learning and AI

John O’Reilly, global managing director of Unispace Life Sciences, says many life science companies many organisations are implementing newer initiatives such as Pharma 4.0, digital and sustainability, while simultaneously operating in legacy manufacturing facilities and platforms that require maintenance and recapitalisation.

Life science firms are focused on talent retention and tech skills as they embrace new initiatives such as Pharma 4.0, digital and sustainability, according to an in-depth new report.

The Unispace Life Sciences ‘Forefront’ report sheds light on advancements in manufacturing processes, digitisation, compliance, or quality, and the way the sector researches and commercialises drug products is constantly evolving.